Fig. 1: High DLST expression is associated with poor overall and recurrence-free survival in TNBC patients.

a, b In silico Kaplan–Meier analysis of the breast cancer patients (http://kmplot.com/analysis/). The curves demonstrate the association of DLST expression with overall (a) and recurrence-free (b) survival in patients over time. Overall survival: n = 720 for ER+, n = 349 for ER−, and n = 153 for TNBC; and recurrence-free survival: n = 2561 for ER+, n = 796 for ER−, and n = 392 for TNBC. Patient samples were stratified using the best cut-off and compared with the log-rank test for statistical significance between curves.